Evidence map›Paper›PMID 27438055›Full record

Trial reportInternational urogynecology journal2017

Short-term Uresta efficacy (SURE) study: a randomized controlled trial of the Uresta continence device.

Danny Lovatsis, Carolyn Best, Phaedra Diamond

3 registry-linked trialsAbstract readRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in International urogynecology journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03614611 naterminatednot on this mapstarted 2018, after this paper: background citation

Canadian Experience With Contiform Intravaginal Device For The Treatment Of Stress Incontinence: Effectiveness And Patient Acceptability

TypeinterventionalSponsorCHU de Quebec-Universite LavalRan2018 to 2022Enrolled39ConditionsUrinary Incontinence, StressArmsContiform pessary
NCT07103161 narecruitingnot on this mapstarted 2022, after this paper: background citation

Does a Regular Tampon or Intravaginal Pessary Mitigate Urine Leakage While Running Among Females Who Experience Exercise-induced Urinary Incontinence?

TypeinterventionalSponsorUniversity of OttawaRan2022 to 2026Enrolled30ConditionsStress Urinary Incontinence (SUI)ArmsUresta bladder support device, Sportex regular tampon
NCT07706491 nacompletednot on this mapstarted 2026, after this paper: background citation

A Uresta Bladder Support Handle Comparison Study

TypeinterventionalSponsorResilia Inc.Ran2026 to 2026Enrolled113ConditionsStress Urinary Incontinence (SUI)Armspessary handle
3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2026
    Review
  5. Diagnosis and management of urinary incontinence in females.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2026
    Review
  6. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Danny LovatsisDivision of Urogynaecology and Reconstructive Pelvic Surgery, Mount Sinai Hospital and University of Toronto, 700 University Avenue, Room 8-814, Toronto, ON, Canada, M5G 1Z5. dlovatsis@mtsinai.on.ca.ORCID http://orcid.org/0000-0002-0629-6645
Carolyn BestDivision of Urogynaecology and Reconstructive Pelvic Surgery, Mount Sinai Hospital and University of Toronto, 700 University Avenue, Room 8-814, Toronto, ON, Canada, M5G 1Z5.
Phaedra DiamondDivision of Urogynaecology and Reconstructive Pelvic Surgery, Mount Sinai Hospital and University of Toronto, 700 University Avenue, Room 8-814, Toronto, ON, Canada, M5G 1Z5.
Mount Sinai Hospital · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introduction and hypothesisAn intravaginal device (Uresta) is currently available for the treatment of stress urinary incontinence (SUI). Case-series data on its effectiveness exist; however, controlled data are lacking. The objective of this study is to determine the short-term efficacy of the Uresta device using a randomized placebo controlled trial. The hypothesis is that the Uresta device might significantly reduce urinary loss.

methodsA single blind randomized controlled trial was conducted among women with urodynamic SUI recruited from a single urogynecology unit. Participants were randomized to receive the Uresta device or a placebo vaginal silastic ring placed high in the vagina for the duration of a pad test. Pad tests were performed before and after device placement. The primary outcome was the achievement of a 50 % or greater reduction in pad weight after device placement, in a comparison of the two groups. Sample size calculation showed a need for 18 subjects per group. Fisher's exact test was used to analyze the primary outcome. Research Ethics Board approval was obtained.

resultsEighteen subjects per group completed the study protocol. The percentage of patients who achieved the primary outcome was 66.7 % in the Uresta group and 22.2 % in the placebo group (p = 0.01). The baseline demographic data were similar in the two groups. There were no adverse events during the test period.

conclusionsThe Uresta intravaginal continence device significantly reduces the short-term objective measures of urine loss due to SUI. Further study to assess subjective outcomes and long-term patient satisfaction is required.

Indexed as

AdultFemaleHumansMiddle AgedPessariesSingle-Blind MethodTreatment OutcomeUrinary Incontinence, StressUrodynamicsVaginaStress urinary incontinenceUresta continence device

Identifiers

PMID27438055
OpenAlexW2491446730

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.